Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1799]
News [2695]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Paediatric leukaemia treatment regimens lead to improved outcomes in...
Dr Wendy Stock - University of Chicago, Chicago, USA
Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults ( Dr Wendy Stock - University of Chicago, Chicago, USA )
7 Dec 2014
Targeted therapy effective in elderly patients with Philadelphia-positive acute...
Dr Oliver Ottmann - Goethe University, Frankfurt, Germany
Targeted therapy effective in elderly patients with Philadelphia-positive acute lymphocytic leukaemia ( Dr Oliver Ottmann - Goethe University, Frankfurt, Germany )
7 Dec 2014
Children with rare leukaemia have better-than-expected outcomes after tailored...
Dr Brent Wood - Seattle Children's Hospital, Seattle, USA
Children with rare leukaemia have better-than-expected outcomes after tailored treatment ( Dr Brent Wood - Seattle Children's Hospital, Seattle, USA )
7 Dec 2014
First randomised evidence for benefit from adding a tyrosine kinase inhibitor...
Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany
First randomised evidence for benefit from adding a tyrosine kinase inhibitor in acute myeloid leukaemia ( Dr Christoph Röllig - University Hospital Dresden, Dresden, Germany )
7 Dec 2014
Compound improves survival in aggressive acute myeloid leukaemia with...
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
7 Dec 2014
ASH 2014: Expert discussion on the latest in AML
Prof Alan Burnett and Prof Sergio Amadori
ASH 2014: Expert discussion on the latest in AML ( Prof Alan Burnett and Prof Sergio Amadori )
7 Dec 2014
ASH 2014: Expert discussion on the latest in CLL
Prof John Gribben and Prof Stephan Stilgenbauer
ASH 2014: Expert discussion on the latest in CLL ( Prof John Gribben and Prof Stephan Stilgenbauer )
7 Dec 2014
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Post-transplant survival boosted by brentuximab vedotin in lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
6 Dec 2014
ecancermedicalscience editor's choice for November 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for November 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
28 Nov 2014
Overcoming cancer resistance with enzyme inhibitors
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Overcoming cancer resistance with enzyme inhibitors ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
27 Nov 2014
New emerging treatments and challenges in MCL, MM and CLL: Expert panel...
Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo
New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion ( Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo )
24 Nov 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation